Investor FAQs
NANOBIOTIX’s ordinary shares are listed on the Euronext Paris Stock Exchange under the symbol “NANO” (Compartment: B, ISIN code: FR0011341205).
NANOBIOTIX’s ordinary shares, in the form of American Depositary Shares, or ADSs, are listed on the Nasdaq Global Select Market under the symbol “NBTX” and sponsored by a depository bank, Citibank N.A.
Citibank, N.A. act as the depositary for the American Depositary Shares. Citibank’s depositary offices are located at 388 Greenwich Street, New York, New York 10013. The depositary typically appoints a custodian to safekeep the securities on deposit. In this case, the custodian is Citibank Europe Plc Dublin (CEP), located at EGSP 186, 1 North Wall Quay, Dublin 1 Ireland.
A depositary is a bank that facilitates cross-border trading of an issuer’s shares. Among other things, depositary banks provide ADS issuance and cancellation services, and associated stock transfer services such as maintaining the register of holders, and providing annual meeting services.
Non-U.S. shareholders can purchase ADSs directly or convert their Euronext Paris ordinary shares into ADSs. We would advise that prospective shareholders seek advice from a broker and/or tax adviser.
Holders of ADSs may authorize Citibank, N.A., Nanobiotix’s Depositary, to act as a proxy in exercising voting rights according to the number of ordinary shares represented by their respective ADSs.
You can register to receive updates announced by NANOBIOTIX by submitting your email address in Email Alerts on the Investor Relations section of our website. Alternatively you can send an email to investor relations requesting to be notified of any new updates announced at investors@nanobiotix.com.
GRANT THORNTON
Membre français de Grant Thornton International
29, rue du Pont
92200 Neuilly-sur-Seine, France
KPMG SA
Tour Eqho
2 avenue Gambetta
92066 Paris La Défense Cedex, France
NANOBIOTIX’s annual reports, interim report and press releases are available on Nanobiotix’s Investors website at ir.nanobiotix.com.
To receive a hard copy of Nanobiotix’s latest annual report, please contact us by emailing investors@nanobiotix.com. Please, note that the company encourages investors to not print the full document to reduce the impact on the environment.
Nanobiotix’s financial year ends on 31 December.